Skip Navigation



International Immunology Advance Access published online on June 11, 2008
International Immunology, doi:10.1093/intimm/dxn060
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/8/1019    most recent
dxn060v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Smithgall, M. D.
Right arrow Articles by Smith, D. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smithgall, M. D.
Right arrow Articles by Smith, D. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Japanese Society for Immunology. 2008. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells

Molly D. Smithgall, Michael R. Comeau, Bo-Rin Park Yoon, Dawn Kaufman, Richard Armitage and Dirk E. Smith

Department of Inflammation Research, Amgen Inc., 1201 Amgen Court West, Seattle, WA, USA

Correspondence to: Correspondence to: D. E. Smith; E-mail: smithde{at}amgen.com

IL-33 is an IL-1 family member recently identified as the ligand for T1/ST2 (ST2), a member of the IL-1 receptor family. ST2 is stably expressed on mast cells and Th2 effector T cells and its function has been studied in the context of Th2-associated inflammation. Indeed, IL-33 induces Th2 cytokines from mast cells and polarized mouse T cells and leads to pulmonary and mucosal Th2 inflammation when administered in vivo. To better understand how this pathway modulates inflammatory responses, we examined the activity of IL-33 on a variety of human immune cells. Human blood-derived basophils expressed high levels of ST2 receptor and responded to IL-33 by producing several pro-inflammatory cytokines including IL-1β, IL-4, IL-5, IL-6, IL-8, IL-13 and granulocyte macrophage colony-stimulating factor. Next, utilizing a human Th2-polarized T cell culture system derived from allergic donor blood cells, we found that IL-33 was able to enhance antigen-dependent and -independent T cell responses, including IL-5, IL-13 and IFN-{gamma} production. IL-33 activity was also tested on V{alpha}24-positive human invariant NKT (iNKT) cells. In the presence of {alpha}-galactosylceramide antigen presentation, IL-33 dose dependently enhanced iNKT production of several cytokines, including both IL-4 and IFN-{gamma}. IL-33 also directly induced IFN-{gamma} production from both iNKT and human NK cells via cooperation with IL-12. Taken together, these results indicate that in addition to its activity on human mast cells, IL-33 is capable of activating human basophils, polarized T cells, iNKT and NK cells. Moreover, the nature of the responses elicited by IL-33 suggests that this axis may amplify both Th1- and Th2-oriented immune responses.

Keywords: cytokines, inflammation, NK cells, Th1/Th2 cells

Transmitting editor: Sergio Romagnani

Received 6 February 2008, accepted 16 May 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. Kurowska-Stolarska, P. Kewin, G. Murphy, R. C. Russo, B. Stolarski, C. C. Garcia, M. Komai-Koma, N. Pitman, Y. Li, A. N. J. McKenzie, et al.
IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4
J. Immunol., October 1, 2008; 181(7): 4780 - 4790.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.